MedPath
HSA Approval

ELOMET OINTMENT 0.1%

SIN07566P

ELOMET OINTMENT 0.1%

ELOMET OINTMENT 0.1%

December 6, 1993

ORGANON SINGAPORE PTE. LTD.

ORGANON SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantORGANON SINGAPORE PTE. LTD.
Licence HolderORGANON SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

OINTMENT

**DOSAGE AND ADMINISTRATION:** A thin film of ELOMET Ointment 0.1% should be applied to the affected skin areas once daily until the lesion heals or for a duration of three weeks, whichever is sooner.

TOPICAL

Medical Information

**INDICATIONS AND USAGE:** ELOMET Ointment 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. The lotion formulation may be applied to scalp lesions.

**CONTRAINDICATIONS:** ELOMET Ointment 0.1% is contraindicated in patients who are sensitive to mometasone furoate, to other corticosteroids or to any component of these preparations.

D07AC13

mometasone

Manufacturer Information

ORGANON SINGAPORE PTE. LTD.

Organon Heist bv

S-P CANADA

PT Organon Pharma Indonesia Tbk

Active Ingredients

MOMETASONE FUROATE ANHYDROUS

0.1%

Mometasone

Documents

Package Inserts

Elomet Ointment PI.pdf

Approved: December 28, 2022

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ELOMET OINTMENT 0.1% - HSA Approval | MedPath